These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4993770)

  • 1. Studies on the thyroid gland component inhibiting LATS.
    Schleusener H; Murthy PV; McKenzie JM
    Metabolism; 1971 Mar; 20(3):299-308. PubMed ID: 4993770
    [No Abstract]   [Full Text] [Related]  

  • 2. [Discrepancy between thyroid stimulation by LATS and inactivation by thyroid microsomes].
    Shishiba Y; Shimizu T; Yoshimura S; Shizume K
    Nihon Naibunpi Gakkai Zasshi; 1970 May; 46(2):122-6. PubMed ID: 5463390
    [No Abstract]   [Full Text] [Related]  

  • 3. Neutralization of the long-acting thyroid stimulator by thyroid subcellular fractions.
    Berumen FO; Lobsenz IL; Utiger RD
    J Lab Clin Med; 1967 Oct; 70(4):640-9. PubMed ID: 6072404
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of the long-acting thyroid stimulator (LATS) by soluble thyroid fractions.
    Beall G; Doniach D; Roitt I; el Kabir D
    J Lab Clin Med; 1969 Jun; 73(6):988-99. PubMed ID: 4977698
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the interaction of long-acting thyroid stimulator (LATS) with soluble thyroid fractions.
    Amino N; Miyai K; Azukizawa M; Kumahara Y
    Acta Endocrinol (Copenh); 1971 Dec; 68(4):625-44. PubMed ID: 5171628
    [No Abstract]   [Full Text] [Related]  

  • 6. LATS inhibition by a soluble lipoprotein from human thyroid gland.
    Chopra IJ; Beall GN; Solomon DH
    J Clin Endocrinol Metab; 1971 Jun; 32(6):772-8. PubMed ID: 5577160
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative studies on the properties of LATS and TSH.
    Ochi Y; Degroot LJ
    Endocrinol Jpn; 1970 Apr; 17(2):131-41. PubMed ID: 4989458
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of the thyroid-stimulating globulin (LATS) by particulate and soluble cell fractions.
    Benhamou-Glynn N; el-Kabir DJ; Doniach D; Roitt IM
    Proc R Soc Med; 1968 Dec; 61(12):1303-5. PubMed ID: 4178461
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolation of the thyroid peroxidase complex.
    Danner DJ; Morrison M
    Biochim Biophys Acta; 1971 Apr; 235(1):44-51. PubMed ID: 4996829
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
    [No Abstract]   [Full Text] [Related]  

  • 11. Purification and characterization of long-acting thyroid stimulator inhibiting factor from human thyroid tissues.
    Sato S; Noguchi S; Noguchi A
    Biochim Biophys Acta; 1972 Jul; 273(2):299-307. PubMed ID: 4673110
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct evidence for human thyroidal stimulation by LATS-protector.
    Shishiba Y; Shimizu T; Yoshimura S; Shizume K
    J Clin Endocrinol Metab; 1973 Mar; 36(3):517-21. PubMed ID: 4739312
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies.
    Mori T; Fisher J; Kriss JP
    J Clin Endocrinol Metab; 1970 Aug; 31(2):119-33. PubMed ID: 4193195
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inactivation of the thyroid-stimulating and exophthalmogenic effect of TSH, LATS, EPF, thyroid antibodies and serum protein fractions by iodine].
    Schemmel K; Streich D; Kreysing G; Leybold K; Weisbecker L
    Klin Wochenschr; 1969 Aug; 47(16):879-83. PubMed ID: 5393915
    [No Abstract]   [Full Text] [Related]  

  • 15. TSH- or LATS-stimulated thyroid hormone release is inhibited by iodide.
    Ochi Y; DeGroot LJ
    Endocrinology; 1969 Jun; 84(6):1305-9. PubMed ID: 5781122
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction of purified long-acting thyroid stimulator (LATS) and thyroid microsomes in vitro.
    Wong ET; Litman GW
    J Clin Endocrinol Metab; 1969 Jan; 29(1):72-8. PubMed ID: 5762323
    [No Abstract]   [Full Text] [Related]  

  • 17. LATS protector, the human thyroid stimulator.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
    [No Abstract]   [Full Text] [Related]  

  • 18. Thyroid-stimulating activity in the serum of immunized rabbits. II. Nature of the thyroid-stimulating material.
    Solomon DH; Beall GN
    J Clin Endocrinol Metab; 1968 Oct; 28(10):1496-502. PubMed ID: 5681643
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterisation of long-acting thyroid stimulator gamma-G binding protein.
    Smith BR
    Biochim Biophys Acta; 1971 Mar; 229(3):649-62. PubMed ID: 4929149
    [No Abstract]   [Full Text] [Related]  

  • 20. ["Long-acting thyroid stimulator" (LATS) and conventional thyroid antibodies. Comparative studies].
    Depisch D; Höfer R; Schatz H
    Wien Z Inn Med; 1968; 49(11):418-22. PubMed ID: 5737591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.